Aloni-Grinstein Ronit, Charni-Natan Meital, Solomon Hilla, Rotter Varda
Department of Molecular Cell Biology, Weizmann Institute of Science, 76100 Rehovot, Israel.
Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Box 19, 74100 Ness-Ziona, Israel.
Cancers (Basel). 2018 Jun 4;10(6):178. doi: 10.3390/cancers10060178.
The discovery of the tumor suppressor p53, through its interactions with proteins of tumor-promoting viruses, paved the way to the understanding of p53 roles in tumor virology. Over the years, accumulating data suggest that WTp53 is involved in the viral life cycle of non-tumor-promoting viruses as well. These include the influenza virus, smallpox and vaccinia viruses, the Zika virus, West Nile virus, Japanese encephalitis virus, Human Immunodeficiency Virus Type 1, Human herpes simplex virus-1, and more. Viruses have learned to manipulate WTp53 through different strategies to improve their replication and spreading in a stage-specific, bidirectional way. While some viruses require active WTp53 for efficient viral replication, others require reduction/inhibition of WTp53 activity. A better understanding of WTp53 functionality in viral life may offer new future clinical approaches, based on WTp53 manipulation, for viral infections.
肿瘤抑制因子p53通过与促肿瘤病毒的蛋白质相互作用被发现,为理解p53在肿瘤病毒学中的作用铺平了道路。多年来,越来越多的数据表明野生型p53也参与了非促肿瘤病毒的病毒生命周期。这些病毒包括流感病毒、天花和痘苗病毒、寨卡病毒、西尼罗河病毒、日本脑炎病毒、人类免疫缺陷病毒1型、人类单纯疱疹病毒1型等等。病毒已经学会通过不同策略操纵野生型p53,以阶段特异性、双向的方式促进其复制和传播。虽然一些病毒高效复制需要有活性的野生型p53,但另一些病毒则需要降低/抑制野生型p53的活性。更好地理解野生型p53在病毒生命周期中的功能,可能会基于对野生型p53的操控,为病毒感染提供新的未来临床治疗方法。